Skip to main content

Crestline Management, L.P.

Position in DNLI — Denali Therapeutics Inc.

CIK 1536054 FORT WORTH, TX

Position in DNLI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$49,144,027
+$6,697,973 QoQ
Shares Held
1,910,732
-13.6% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
91.90%
of 13F equity value
Holder Rank
#24
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Crestline Management, L.P. holds $51,781,545 across 2 Biotechnology names. DNLI ranks #1 (94.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DNLI
Denali Therapeutics Inc.
This page
1,910,732 $49,144,027

All Filings in DNLI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $49,144,027 1,910,732
2026-03-31 $42,446,054 2,210,732
2025-12-31 $46,405,185 2,810,732
2025-09-30 $49,523,828 3,410,732
2025-06-30 $54,011,640 3,860,732
2025-03-31 $56,565,151 4,160,732
2024-12-31 $87,852,718 4,310,732
2024-09-30 $129,941,123 4,460,732
2024-06-30 $110,544,197 4,760,732
2024-03-31 $106,924,220 5,210,732
2023-12-31 $121,479,308 5,660,732
2023-09-30 $122,969,901 5,960,732
2023-06-30 $180,327,701 6,110,732
2023-03-31 $147,703,265 6,410,732
2022-12-31 $190,796,956 6,860,732
2022-09-30 $219,762,865 7,160,732
2022-06-30 $219,569,342 7,460,732
2022-03-31 $240,011,748 7,460,732
2021-12-31 $343,644,739 7,705,039
2021-09-30 $388,719,217 7,705,039
2021-06-30 $638,147,129 8,135,481
2021-03-31 $570,134,135 9,984,836
2020-12-31 $1,630,179,000 19,462,500
2020-09-30 $437,184,546 12,201,634
2020-06-30 $329,933,222 13,644,881
2020-03-31 $272,591,057 15,567,736